We are live on ! Find out more
DIG

Dauntless Investment Group Portfolio holdings

AUM $127M
1-Year Est. Return 42.43%
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+42.43%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$127M
AUM Growth
-$23.8M
Cap. Flow
+$27.3M
Cap. Flow %
21.46%
Top 10 Hldgs %
72.38%
Holding
99
New
30
Increased
18
Reduced
19
Closed
26

Top Buys

Rank Stock Value
1
FEMY icon
Femasys
FEMY
+$10.9M
2
AEON icon
AEON Biopharma
AEON
+$8.33M
3
KZIA
Kazia Therapeutics
KZIA
+$3.34M
4
VLO icon
Valero Energy
VLO
+$2.61M
5
AZTR icon
Azitra
AZTR
+$2.44M

Sector Composition

Rank Sector Weight
1 Miscellaneous 54.7%
2 Healthcare 30.91%
3 Real Estate 3.75%
4 Consumer Staples 3.62%
5 Energy 2.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRAW icon
51
Traws Pharma
TRAW
$8.45M
$67.9K 0.05%
80,574
-336,424
-81% -$464K
ERNA icon
52
Eterna Therapeutics
ERNA
$5.03M
$39.9K 0.03%
6,000
-18,498
-76% -$131K
INVA icon
53
Innoviva
INVA
$1.54B
$36.8K 0.03%
1,620
-120,782
-99% -$2.76M
CIB icon
54
Grupo Cibest SA
CIB
$23.8B
$35.2K 0.03%
+443
New +$32K
AEM icon
55
Agnico Eagle Mines
AEM
$104B
$25.6K 0.02%
165
-107
-39% -$19.8K
COLO
56
Global X MSCI Colombia ETF
COLO
$224M
$21.1K 0.02%
+507
New +$20.3K
HSAI
57
Hesai Group
HSAI
$2.97B
$20K 0.02%
+1,100
New +$22.5K
RTAC
58
Renatus Tactical Acquisition Corp I
RTAC
$329M
$19K 0.01%
1,813
TVA
59
Texas Ventures Acquisition III Corp
TVA
$316M
$8.49K 0.01%
805
-3,213
-80% -$33.7K
JBS
60
JBS N.V.
JBS
$42.9B
$7.99K 0.01%
674
-20,634
-97% -$302K
AEXA
61
American Exceptionalism Acquisition Corp
AEXA
$564M
$7.92K 0.01%
670
CRIS icon
62
Curis
CRIS
$3.27M
$5.22K ﹤0.01%
500
-32,436
-98% -$333K
DSL
63
DoubleLine Income Solutions Fund
DSL
$1.2B
$3.61K ﹤0.01%
326
PPLT
64
abrdn Physical Platinum Shares ETF
PPLT
$2.23B
$3.39K ﹤0.01%
240
DC icon
65
Dakota Gold
DC
$798M
$2.48K ﹤0.01%
581
-68,460
-99% -$369K
NWAX.U
66
New America Acquisition I Corp Units
NWAX.U
$1.79K ﹤0.01%
172
POWL icon
67
Powell Industries
POWL
$6.6B
$286 ﹤0.01%
+1
New +$271
INMB icon
68
INmune Bio
INMB
$67.7M
$163 ﹤0.01%
100
-183,376
-100% -$254K
LCTX icon
69
Lineage Cell Therapeutics
LCTX
$273M
$131 ﹤0.01%
+100
New +$138
CAPR icon
70
Capricor Therapeutics
CAPR
$547M
$24 ﹤0.01%
1
-14,069
-100% -$427K
TRVI icon
71
Trevi Therapeutics
TRVI
$2.46B
$19 ﹤0.01%
+1
New +$15
HCAC
72
Hall Chadwick Acquisition Corp
HCAC
$295M
$10 ﹤0.01%
+1
New +$10
NAK
73
Northern Dynasty Minerals
NAK
$826M
$2 ﹤0.01%
1
ACIU icon
74
AC Immune
ACIU
$284M
-107,489
Closed -$296K
ACON icon
75
Aclarion
ACON
$6.77M
-5,422
Closed -$17.7K

Similar funds

Dauntless Investment Group's Q2 2026 Portfolio in Review

As of Q2 2026, Dauntless Investment Group held 99 positions worth $127M, down 16% from $151M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Dauntless Investment Group deployed $27.3M of net new capital in Q2 2026, opening 30 new positions and adding to 18 existing holdings. Its largest new stake was Valero Energy: 10,620 shares worth $2.77M.

By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, down from 76% a quarter earlier, followed by Healthcare and Real Estate.

On the sell side, the largest reduction was Innoviva, an estimated $2.76M trimmed.

  • Dauntless Investment Group's largest Q2 2026 buy was Valero Energy: 10,620 shares worth $2.77M.
  • Dauntless Investment Group added most to Femasys in Q2 2026, an estimated $10.9M increase.
  • Dauntless Investment Group's biggest Q2 2026 reduction was Innoviva, cutting an estimated $2.76M.
  • Dauntless Investment Group fully exited Copa Holdings in Q2 2026, selling an estimated $489K.
  • Dauntless Investment Group's ten largest holdings make up 72% of its $127M portfolio in Q2 2026.
  • Dauntless Investment Group opened 30 new positions and closed 26 in Q2 2026.
  • Dauntless Investment Group's portfolio value fell 16% quarter-over-quarter to $127M.

Based on Dauntless Investment Group's 13F filing for Q2 2026, filed 13 Aug 2026.